| Endocrine and metabolic changes in women with polycystic ovaries and with polycystic ovary syndrome | ||
|---|---|---|
| Prev | Next | |
androstenedione
adrenocorticotropic hormone
area under curve
body mass index
clomiphene citrate
confidence interval
cyproterone acetate
dehydroepiandrosterone
dehydroepiandrosterone sulphate
5α-dihydrotestosterone
diabetes mellitus
deoxyribonucleic acid
estradiol
free androgen index
free fatty acid
functional ovarian hyperandrogenism
follicle stimulating hormone
gestational diabetes mellitus
glucose transporter
gonadotrophin releasing hormone
gonadotrophin releasing hormone agonist
high density lipoprotein
human chorionic gonadotrophin
human menopausal gonadotrophin
17-hydroxyprogesterone
impaired fasting glucose
insulin-like growth factor
insulin-like growth factor binding protein
impaired glucose tolerance
insulin receptor substrate
in vitro fertilization
intravenous glucose tolerance test
low density lipoprotein
luteinizing hormone
monoclonal antibody
multifollicular ovaries
neuropeptide Y
oral contraceptive
oral glucose tolerance test
plasminogen activator inhibitor
polycystic ovaries
polycystic ovary syndrome
cholesterol side chain cleavage enzyme
cytochrome P450
radioimmunoassay
ribonucleic acid
recurrent spontaneous abortion
standard deviation
standard error
sex hormone binding globulin
testosterone
total area
triglycerides
very low-density lipoprotein
variant type of luteinizing hormone
waist-hip ratio